Hans Stefan, Kaslin Jan, Freudenreich Dorian, Brand Michael
Biotechnology Center and Center for Regenerative Therapies Dresden, Dresden University of Technology, Dresden, Germany.
PLoS One. 2009;4(2):e4640. doi: 10.1371/journal.pone.0004640. Epub 2009 Feb 27.
Conventional use of the site-specific recombinase Cre is a powerful technology in mouse, but almost absent in other vertebrate model organisms. In zebrafish, Cre-mediated recombination efficiency was previously very low. Here we show that using transposon-mediated transgenesis, Cre is in fact highly efficient in this organism. Furthermore, temporal control of recombination can be achieved by using the ligand-inducible CreER(T2). Site-specific recombination only occurs upon administration of the drug tamoxifen (TAM) or its active metabolite, 4-hydroxy-tamoxifen (4-OHT). Cre-mediated recombination is detectable already 4 or 2 hours after administration of TAM or 4-OHT, demonstrating fast recombination kinetics. In addition, low doses of TAM allow mosaic labeling of single cells. Combined, our results show that conditional Cre/lox will be a valuable tool for both, embryonic and adult zebrafish studies. Furthermore, single copy insertion transgenesis of Cre/lox constructs suggest a strategy suitable also for other organisms.
位点特异性重组酶Cre的传统应用在小鼠中是一项强大的技术,但在其他脊椎动物模型生物中几乎不存在。在斑马鱼中,Cre介导的重组效率以前非常低。在此我们表明,利用转座子介导的转基因技术,Cre在这种生物中实际上效率很高。此外,通过使用配体诱导型CreER(T2)可实现重组的时间控制。位点特异性重组仅在给予药物他莫昔芬(TAM)或其活性代谢物4-羟基他莫昔芬(4-OHT)时发生。给予TAM或4-OHT后4小时或2小时即可检测到Cre介导的重组,表明重组动力学很快。此外,低剂量的TAM可实现单细胞的镶嵌标记。综合来看,我们的结果表明,条件性Cre/lox对于斑马鱼胚胎和成体研究都将是一种有价值的工具。此外,Cre/lox构建体的单拷贝插入转基因技术提示了一种也适用于其他生物的策略。